Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hodge, Theo
EBONI, NCT05514509: A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories	Recruiting	4	250	US	APRETUDE, Cabotegravir tablet	ViiV Healthcare	HIV Infections	09/25	09/25
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab	Recruiting	N/A	600	US	No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment	Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research	HIV Infections, Multi-Antiviral Resistance	06/25	12/25
Monson, Erich
NCT04561258: Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy	Completed	1	7	US	AGT103-T	American Gene Technologies International Inc.	HIV	08/22	11/22
Sawney, Shari
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab	Recruiting	N/A	600	US	No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment	Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research	HIV Infections, Multi-Antiviral Resistance	06/25	12/25